Unlocking the future of biomanufacturing @thinkagainbio. Former vc @ Atlantic Labs, active angel investor. Lover of science, technology, and @fcbayern.
Decline: German industrial production down to the level of 2005
Yet, the FT journalists studiously avoid mentioning the elephant in the room:
Extremely high energy prices, mostly because of climate policy
https://t.co/xiCA3aiQkX
Venture capital is investing in the future. The kind of companies a fund backs is representative of their vision for the future. Some funds back slop, some back flying cars. It should matter more than other assets that are more value extractive than creative.
venture is the last major asset class where the morality/prestige of a capital provider has any bearing on the underlying asset.
no one thinks twice about who else their credit provider is lending to. private equity firms hold all kinds of sin co's quietly. why does VC care?
@WillManidis Venture capital is investing in the future. The kind of companies a fund backs is representative of their vision for the future. Some funds back slop, some back flying cars. It should matter more than other assets that are more value extractive than creative.
Biology is not as “mainstream” as it should be because 1) it’s complicated and 2) we aren’t great at manipulating it yet.
As we get better, through both AI and non-AI driven progress, we will increasingly unlock the largest and most important market there is, which will drive biology to the forefront of culture the same way AI is today.
Biology is not as “mainstream” as it should be because 1) it’s complicated and 2) we aren’t great at manipulating it yet.
As we get better, through both AI and non-AI driven progress, we will increasingly unlock the largest and most important market there is, which will drive biology to the forefront of culture the same way AI is today.
Biotechnology is about the predictable engineering of life, such that we can protect it and proliferate it through the Universe.
Biotechnology ought to cure all complex diseases (so far, we have cured zero.) It ought to prevent infectious diseases, and remove needless suffering for all animals. And it will (indeed, it already has) expand human healthspan, such that we can enjoy more time on this planet.
But biotechnology is also about protecting biodiversity, and keeping animals from going extinct (or bringing back extinct animals, if needed). It is about growing more abundant and nutritious food. And it is for cleaning up the environment, the atmosphere, and our polluted waters.
Biotechnology is needed to make us a space-faring civilization; to protect us from harmful radiation, or preserve our bodies, as we fly through the cosmos. It is what will enable us to create the microbes needed to terraform Mars or other planets.
It should not seem insane to write this stuff out, because these really are the objectives. Every new tool and every new technology is taking us closer to these destinies. Raise your ambitions.
We have been working with Christophe for a few months and he has already played a critical role in helping Again become a leading global biomanufacturing company.
@wolfejosh@GavinSBaker This take is correct. Environmentalists and regulators (especially in Europe) have done nothing but harm whilst Elon (like him or not) has actually made progress. Economics and unburdened entrepreneurship are the solution.
@cyantist A pretty good writer said “The test of a first-rate intelligence is the ability to hold two opposed ideas in the mind at the same time, and still retain the ability to function”
None of this would have been possible without the amazing work of the entire Again team, who are pushing the boundaries of biotechnology to solve the climate crisis.
We @thinkagainbio have raised $43 million in series A financing to continue on our mission to decarbonise heavy industry by capturing and converting industrial waste gases and recycling them into valuable products.
Grateful to our new and existing investors for supporting us on this journey as well as the many partners we collaborate with daily. cc @HV_Capital@GVteam @kompas_vc @Eifo_fond
By combining our CO2-eating bacteria with cutting-edge technology, we're on a mission to turn CO2 into valuable materials.
We are excited to lift the lid on our first production facility, which went live in late 2023 in Copenhagen.
https://t.co/v1MYPlbC5I